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Summary This study aimed to examine the extent and determinants of patient and general practitioner delay in the presentation of breast
cancer. One hundred and eighty-five cancer patients attending a breast unit were interviewed 2 months after diagnosis. The main outcome
measures were patient delay in presentation to the general practitioner and non-referral by the general practitioner to hospital after the
patient's first visit. Nineteen per cent of patients delayed 2 12 weeks. Patient delay was related to clinical tumour size >4 cm (P= 0.0002) and
with a higher incidence of locally advanced and metastatic disease (P = 0.01). A number of factors predicted patient delay: initial breast
symptom(s) that did not include a lump (OR 4.5, P=0.003), notdisclosing discovery ofthe breast symptom immediately to someone else (OR
6.0, P < 0.001), seeking help only after being prompted by others (OR 4.4, P= 0.007) and presenting to the general practitioner with a non-
breast problem (OR 3.5, P = 0.03). Eighty-three per cent of patients were referred to hospital directly aftertheir first general practitioner visit.
Presenting to the GP with a breast symptom that did not include a lump independently predicted general practitioner delay (OR 3.6,
P = 0.002). In view of the increasing evidence that delay adversely affects survival, a large multicentre study is now warranted to confirm
these findings that may have implications for public and medical education.
Keywords: patient delay; GP delay; breast cancer; psychological response; type of symptom
For women who present with symptomatic breast cancer there is,
by definition, an interval between first detection of symptoms
(either by the woman herself or by another) and the time ofdiag-
nosis and treatment. Prolonged delays, usually defined arbitrarily
as intervals greater than 12 weeks, occurring during this period
have been shown to be associated with increased tumour size
(Fisher et al, 1977; Pilipshen et al, 1984; GIVIO, 1986; Neave et
al, 1990; Rossi et al, 1990) and more advanced stage of disease
(Elwood and Moorehead, 1980; Gould-Martin et al, 1982;
Robinson et al, 1984; GIVIO, 1986; Machiavelli et al, 1989; Rossi
et al, 1990) and with poor long-term survival (Neave et al, 1990;
Afzelius et al, 1994).
Given this relationship between delay, stage and survival, it is
important to assess in detail the different phases ofdelay between
first detection of a symptom and treatment being commenced. For
each of these phases, factors need to be identified that are associ-
ated with prolonged delays, so that effective strategies can be
planned to reduce the overall interval between first symptom and
treatment.
The phases ofdelay can be considered as follows:
1. Patient delay. The interval between first detection ofa
symptom and first presentation to a health professional,
usually a general practitioner (GP).
2. GP delay. The interval between first presentation to a GP and
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3. Hospital delay. The interval between referral and commence-
ment oftreatment. This interval can be further subdivided into
the time before first hospital visit, the time between first visit
and definitive diagnosis and the time between diagnosis and
start oftreatment.
This study examines patient and GP delay in a prospective
cohort of women presenting to the Guy's breast unit with symp-
toms that they had discovered themselves. The contribution of
tumour-related and psychological factors to each phase of delay
has been assessed. The influence of personal characteristics,
including age, marital status, social class, previous psychological
history, previous benign breast disease, breast self-examination
and attendance for mammography, has also been examined, as
previous research has suggested that they may be contributory
factors (Facione, 1993).
SUBJECTS AND METHODS
The subjects eligible for this study were 196 women, presenting
between June 1992 and July 1994 to the breast unit at Guy's
Hospital, in whom a diagnosis ofinvasive breast cancer had been
made. They included (1) a consecutive series ofpatients under the
age of60 years presenting with any stage ofcancer (n = 141) and
(2) a case-control study ofpatients aged 60 years or over (n = 55),
comprising a consecutive series of women with stage III and IV
disease each matched with two patients, one with operable disease
< 4 cm and one with operable disease 2 4 cm. The patients under
60 years of age formed part of a prospective cohort being studied
in relation to a number ofpsychosocial parameters, including life
events, mood disorder and delay. For patients over 60 years, a
case-control design approach was adopted to make the most effec-
tive use of limited resources. As the study was concerned with
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Table 1 Personal and clinicopathological characteristics of patients (n= 185)
Consecutive series Case-control study Total
n=132 n=53 n=185
(age < 60 years) (age .60years)
Mean age (years) 47 70 54
Marital status [- (%)]
Married/cohabiting 94 (71) 26 (49) 120 (65)
Widowed 3 (2) 12 (21) 14 (7)
Divorced/separated 21 (16) 6 (11) 27 (15)
Single 14 (11) 10 (19) 24 (13)
Social class [- (%)]
Professional 12 (9) 4 (9) 16 (9)
Intermediate 39 (30) 10 (21) 49 (27)
Skilled (manual/non) 50 (38) 28 (60) 78 (44)
Partly skilled 11 (8) 1 (2) 12 (7)
Unskilled 19 (15) 4 (9) 23 (13)
Unknown 1 6 7
Previous psychological treatment [- (%)]
No previous treatment 107 (81) 42 (81) 149 (82)
Treatment by GP 14(11) 7(13) 21 (12)
Psychiatric outpatient 9 (7) 2 (4) 11 (6)
Psychiatric inpatient 0 1 (2) 1 (1)
Unkown 2 1 3
Tumour size (clinical) [- (%)]
<4cm 83 (63) 22 (42) 105 (57)
.4cm 49 (37) 31 (58) 80 (43)
Tumour stage [- (%)]
I/ll 113 (86) 36 (68) 149 (81)
III/IV 19 (14) 17 (32) 36 (19)
Nature of first symptom [-(%)]
With lump
Without lump 96 (73) 33 (62) 129 (70)
36 (27) 20 (38) 56 (30)
women who had detected their symptoms themselves, patients
whopresented via the National BreastScreeningProgramme were
not included.
A simplified staging classification was used for this study.
Patients were classified as having either operable disease (stage
MI/I), locally advanced inoperable (stage III) or metastatic disease
(stage IV) at the time of diagnosis. The operable category was
further subdivided according to the tumour size, using a cut-off of
4 cm, as this is taken as the upperlimitforbreast-conserving surgery.
Women were informed about the study and interviewed by a
researchpsychologistapproximately 8 weeks afterdiagnosis while
attending for treatment at the breast unit. Sociodemographic data
were gathered and a history ofpresentation was elicited, using a
semi-structured interviewdeveloped for the study. The semi-struc-
tured interview was developed on the basis of qualitative inter-
views with 20 breast cancerpatients, using questions derived from
previous research findings in this area. The interview was then
piloted and refinedbefore the mainstudy. Theinterview details the
course of events from discovery ofthe initial symptomthrough to
diagnosis and treatment. Time intervals between key events were
established both from this interview and from thepatient's medical
notes to determine the time between discovery of symptoms and
seeing a general practitioner, and between first appointment with
generalpractitioner and onward referral. The nature ofthe first and
any subsequent breast symptoms wereelicited, as well aspatients'
cognitive, emotional and behavioural responses to thediscovery of
their symptom. These responses were classified as follows:
1. patients' attributions oftheir symptom(s) [particular (e.g.
'cancer'/'something serious') vs 'benign breastproblem' vs
'vague' (e.g. didn't think much ofit)/'none'];
2. fear ofsymptom(s) (marked/moderate vs some/none);
3. amount oftime spentthinking about symptom(s)
(marked/moderate vs some/none);
4. disclosing the discovery ofsymptom(s) to someone else within
1 week (yes vs no);
5. source ofmotivation for attending general practitioner (selfvs
other);
6. reason forattending general practitioner (breast symptom(s) vs
otherreason).
In addition, information was gathered regarding previous
psychological treatment, previous breast problems, past breast
self-examination habits, previous routine mammography atten-
dance andpersonalexperience ofcancerinfamily andfriends. The
interviews were tape recorded to enable subsequent scoring
according to predefinedrating criteria.
Statistical analysis
For comparability with most other reported studies, an arbitrary
cut-off for duration of symptoms of at least 12 weeks before the
first visit to a GP was used to define patient delay. General practi-
tioner delay was defined as failure to refer a patient after the first
attendance, as it has been shown by others that most women who
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are subsequently proven to have breast cancer are referred to
hospital immediately after their first GP attendance (Jones and
Dudgeon, 1992). Possible associations between each ofthe phases
of delay and other factors were assessed using contingency tables
(chi-square with Yates' correction) analyses. To discover which
factors independently affected each phase ofdelay, logistic regres-
sion analyses were performed.
Inter-rater reliability
Checks ofinter-raterreliability wereperformed on arandom sample
of 10% of tape-recorded interviews. The average percentage
concordance for individual items on the interview was 84%.
RESULTS
Cohort characteristics
Of the 196 patients potentially eligible for study, 185 were
included in this analysis. Three patients declined to participate in
the study, one ofwhom had stage III disease and two had stage IV
disease. Two stage IV patients died before they could be recruited.
A further six cases (3%) were excluded from the study because
their breast lump was first detected by a health professional during
a health check for hormone replacement therapy (n = 4), during a
check associated with a cervical smear (n = 1) or on admission to
hospital for pneumonia (n = 1). In each case, the patient reported
being unaware ofany breastproblem before the examination. Four
of these women had an operable tumour < 4 cm, one had an
operable tumour 2 4 cm and one had stage IV disease. Four
of the patients had received previous psychiatric treatment. The
sociodemographic and clinicopathological characteristics of the
remaining 185 patients are shown in Table 1.
Patient delay
Of the 185 women who discovered their breast symptoms them-
selves, 42% presented to their general practitioner within 2 weeks
ofthat discovery and 137 (74%) within 8 weeks (Table 2). Thirty-
six patients (19%) delayedtheirpresentation for 12 ormore weeks,
the delay being more than 1 yearin six cases. The extentofpatient
delay was related to clinical tumour size (P = 0.0002) and to stage
(P = 0.01) (Table 2).
One hundred and twenty-nine (70%) patients noticed a lump as
theirfirst symptom. These included 94 (51%) who noticed a breast
lump alone and a further 35 (19%) who noticed a lump in associa-
tion with at least one other symptom. The remaining 56 (30%) had
non-lump symptoms (e.g. pain, nipple changes or discharge,
distortion of the breast) but were unaware of a lump. Among
women who noticed a lump (with or without other symptoms) 13
outof 129 (10%) delayed for 12 or more weeks, compared with 23
out of56 (41%) ofthose who were unaware ofalump (P <0.0001)
(Table 2).
None of the personal characteristics examined were signifi-
cantly associated with the extent of patient delay. These included
age (P = 0.1), marital status (P = 0.3), socioeconomic status
(P = 0.3), previous psychological treatment (P = 0.5), previous
benign breast problems (P = 0.3), regular breast self-examination
(P = 0.4), attendance for mammography as part ofNational Breast
Screening Programme (P = 0.3) or personal experience of cancer
in family and friends (P = 0.8).
Womens' psychological responses to the discovery of a breast
symptom were related to the extent of their subsequent delay
(Table 3). Among the whole study sample, 13% of those who
attributed their symptoms to cancerdelayed for 12 weeks or more,
compared with 17% who attributed their symptom to a benign
cause and 38% of those who made a vague or no attribution
(P =0.04). Those whodelayed alsoreported lessfearondiscovering
their symptom (P = 0.05). They were also less likely to disclose
the discovery of the symptom to someone else immediately
(P < 0.0001). They were more likely to be prompted by others to
seek help than to do so of their own volition (P = 0.0001). Those
who delayed were more likely to present to their GP with
non-breast problems (P = 0.0006).
The likelihood of women disclosing the discovery of their first
symptom(s) immediately was associated with whether they lived
with a partner. Sixty-seven per cent of women who were married
or cohabiting disclosed their symptom(s), compared with only
47% ofthose who were single, widowed or divorced (P = 0.02).
Some ofthepsychological responses to thediscovery ofa breast
symptom were related to whether or not the initial symptom
included a lump (Table 3). Those whose symptom included a
breast lump were more likely to attribute their symptom to a
particular cause (P = 0.0001), to experience fear (P = 0.02) and to
think about their symptom for a marked/moderate amount oftime
(P = 0.01).
The independent effect of the following variables on patient
delay was assessed using a logistic regression: nature of first
symptom (lump or no lump); symptom attribution; amount offear
and time spent thinking about the symptom; disclosing to another;
source of motivation and reason for attending the GP. Twenty-
three of the patients did not attend their GP with their first breast
symptom, but did so subsequently when they developed a second
symptom. The analysis therefore includes data for these 23
patients on the source of motivation and reason for attending the
GP in relation to their second symptom.
Table 2 Patient delay according to tumour characteristics (n = 185)
Duration of symptoms Total patients Clinical tumour size Tumour stage Symptom
n(%)
<4cm .4cm [/Al III/IV With lump Without lump
< 1 week 39 (21) 26 (25) 13 (16) 38 (26) 1 (3) 32 (25) 7 (13)
1-<2 weeks 38 (21) 24 (24) 14 (17) 30 (20) 8 (22) 30 (23) 8 (14)
2-< 4 weeks 30 (16) 18 (17) 12 (15) 26 (18) 4 (11) 25 (20) 5 (9)
4-< 8 weeks 30 (16) 20 (19) 10 (13) 22 (15) 8 (22) 24 (19) 6 (11)
8-<12weeks 12(7) 7(7) 5(6) 10(7) 2(6) 5(4) 7(13)
2 12 weeks 36 (19) 10 (10) 26 (33) 23 (15) 13 (36) 13 (10) 23 (41)
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Table 3 Psychological response to discovery of first symptoms according to (1) patient delay and (2) nature of first symptom
Psychological responses Patient delay Nature of symptom
< 12 weeks > 12 weeks P Lump Non-lump P
(n = 149) (n = 36) (n = 129) (n = 56)
Attribution
Cancer 75 (51)a 11 (31) 71 (55) 15 (27)
Benign 48 (32) 10 (28) 0.03 43 (33) 15 (27) 0.0003
Vague/none 25 (17) 15 (42) 15 (12) 25(45)
Missing 1 1
Fear
Marked/moderate 41 (29) 4 (11) 0.05 38 (31) 7 (13) 0.02
Mild/none 99 (71) 31 (89) 84 (69) 46 (87)
Missing 9 1 7 3
Time thinking about symptom
Marked/moderate 27 (20) 2 (6) 0.07 26 (22) 3 (6) 0.01
Mild/none 107 (80) 33 (94) 91 (78) 49 (94)
Missing 15 1 12 4
Disclosing to another
Yes 91 (68) 9 (27) < 0.0001 75 (65) 25 (49) 0.07
No 42 (32) 24 (73) 40 (35) 26 (51)
Missing 16 3 14 5
Motivation for attending GP
Self 133 (90) 21 (62) 0.0001 111 (88) 43 (78) 0.1
Other 14 (10) 13(38) 15 (12) 12 (22)
Missing 2 2 3 1
Reason for attending GP
Breast symptom 133 (90) 22 (65) 0.0006 111 (88) 44 (79) 0.1
Other 15 (10) 12 (35) 15 (12) 12 (21)
Missing 1 2 3
aNumbers in parentheses are percentages.
Type of first symptom, disclosing, source of motivation and
reason for attending GP each independently predict patient delay.
Patients whose first symptom(s) did not include a lump were more
than four times more likely to delay than those whose first
symptom did include a lump (OR 4.5, 95% CI 1.7-12.0,
P = 0.003). Patients who did not disclose the discovery of their
symptoms to anyone within afew days offinding it were six times
more likely to delay than those whodid (OR6.0, 95% CI 2.3-15.9,
P < 0.001). Patients who were prompted by someone else to seek
medical help rather than do so of their own volition were four
times more likely to have delayed (OR 4.4, 95% CI 1.5-13.1,
Table 4 GP delay - all patients
Total Immediate referral Delayed referral
All patients 185 (100)a 153 (83) 32 (17)
Symptoms
Lump 144 (78) 126 (82) 18 (56)
No lump 41 (22) 27 (18) 14 (44)
Age (years)
< 35 8 (4) 4 (3) 4 (13)
35-44 43 (23) 34 (22) 9 (28)
45-54 59 (32) 49 (32) 10 (31)
55-64 34(18) 28(18) 6(19)
.65 41 (22) 38 (25) 3 (9)
aNumbers in parentheses are percentages.
P = 0.007), and those who attended their general practitioner with
a non-breast problem were over three times more likely to have
delayed (OR 3.5, 95% CI 1.1-11.0, P = 0.03).
General practitioner delay
One hundred and fifty-three of the 185 patients (83%) were
referred to hospital directly after their first presentation to the GP.
In theremaining 32 (17%) cases, referral was delayed. In 16 ofthe
delayed cases, referral was made when the patient returned to the
GP with the same symptoms. In the other 16 cases, referral was
made after re-presentation with a second symptom. The interval
between first presentation to the GP and onward referral to
hospital was less than 2 weeks in 75% ofcases, but was in excess
of 12 weeks in 16% of cases. Ten patients (5%) were not referred
for over a year.
Delayed referral by a general practitioner was observed more
frequently among patients who were not aware of a lump at the
time of presentation to the GP (Table 4). Referral was delayed in
14 out of41 (34%) patients whose symptoms at presentation to the
GP did not include a lump, compared with 18 out of 144 (13%) of
those with a lump (P = 0.002). Thus, although only 41 out of 185
(22%) patients did not have a lump among their presenting symp-
toms, non-lump presentations accounted for 14 out of32 (44%) of
all cases ofGP delay.
GP delay was related to the age of the patient, the mean age of
those who experienced GP delay being 49 years, compared with
55 years for those who were referred on immediately (P = 0.01).
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The independent effect of the following variables on GP delays
was assessed using logistic regression: nature of presenting
symptom (lump or no lump); age. Logistic regression showed only
nature of symptom to be independently predictive ofgeneral prac-
titioner delay. Patients whose presenting symptom did not include
a lump were more than three times more likely to have their
onward referral to hospital delayed by their GP (OR 3.6, 95% CI
1.6-8.1, P = 0.002).
Combined patient and GP delay
Despite the fact that non-lump symptoms were a risk factor for
both patient and GP delay, combined patient and GP delay was a
rare phenomenon occurring in only 2 out of 185 patients. This can
be explained in part by the fact that 15 out of 23 patients whose
first symptom did not include a lump and who delayed their
presentation had in fact developed a lump by the time of that
presentation.
DISCUSSION
This study has sought to distinguish between patient and GP delay
by undertaking detailed semistructured patient interviews, in
conjunction with extracting data from medical records to ascertain
dates and time intervals. Using this methodological approach, 19%
of patients with breast symptoms reported delays of 12 weeks or
more before presenting to their GP. This figure is broadly in line
with the range reported by three other UK interview-based studies
of patient delay: Adam et al (1980) reported that 10% of their
sample (all of whom were aged less than 50 years) delayed 12
weeks or more; Cameron and Hinton (1968) reported 23% and
MacArthur and Smith (1981) reported 32%. Differences between
the results of these individual studies may reflect differences in
periods ofaccrual and age characteristics.
The retrospective nature of the data collection on duration of
symptoms, which is intrinsic to any study ofpatient delay, poses a
potential threat to the validity of the findings. The estimates of
duration ofsymptoms could be affected by false reporting or faulty
recall on the part of the women. False reporting, when the patient
tries to justify or rationalize her behaviour, is probably a greater
problem in studies in which duration ofsymptoms is elicited either
byquestionnaire orby a health professional directly involved in the
patient's care. In this study, interviewers were not involved in the
patients' management, the line ofquestioning was non-judgemental
and patients' confidentiality was assured. Like other researchers in
this area who have interviewed women retrospectively about their
breast symptoms, we were impressed by their precision about the
timing of events (Adam et al, 1980; Samet et al, 1988).
The data from this study suggest that these delays may have
important prognostic implications. Our findings support those
from other studies, cited in the introduction, which show a rela-
tionship between delayed presentation and increased tumour size
and stage of disease.
Having presented to a GP, the majority of women (83%) in this
study were referred on to hospital directly after that presentation.
Eighty-two per cent were referred within 4 weeks, which is similar
to the 90% proportion of women referred within 4 weeks reported
in other studies (Nichols et al, 1981; Jones and Dudgeon, 1992).
Also in line with other studies, we found that a small number of
women have their referral delayed for several months after initial
presentation (Adam et al, 1980; MacArthur and Smith, 1981).
This study has examined a range of factors that might influence
patient and GP delay. As far as we are aware, this work isunique in
looking at clinical factors, such as nature of the first breast symp-
toms, alongside women's psychological responses to their symp-
toms and their personal characteristics and in using a systematic
and reliable approach to the assessment of psychological
responses. Ofthe factors examined, discovery of a breast symptom
that did not include a lump was the most significant determinant of
patient delay; an association that has been suggested in other
studies (MacArthur and Smith, 1981; Nichols et al, 1981). A non-
lump symptom was also the only factor that we found to predict
GP delay. The proportion of our sample (30%) reporting that their
first breast symptom did not include a lump was in line with the
proportions reported elsewhere (Adam et al, 1980; Macarthur and
Smith, 1981).
The women whose symptoms did not include a lump responded
differently to the discovery of those symptoms compared with
those who first noticed a lump. Those with non-lump symptoms
were less likely to attribute their symptom to a definite cause and
less likely to report the fears and thoughts that normally prompt
help-seeking behaviour. This lack of psychological response to
discovery of a non-lump breast symptom may be the mechanism
that mediates subsequent delay in presentation. The association
between symptoms that do not include a lump and a lack of subse-
quent emotional response may also explain the relationship
between womens' absence of suspicion and fear and delay
reported by Adam et al (1980) and Cameron and Hinton (1968), as
well as the relationship between 'denial' among women presenting
with symptoms of breast cancer and delay, which is so widely
reported in the social science literature (Henderson, 1966; Greer,
1974; Magarey and Blizzard, 1977; More et al, 1990). None of
these earlier studies had evaluated the type of symptom women
had developed, alongside their psychological responses. If these
findings are confirmed by other work, they would suggest that the
public need to be further educated about breast symptoms other
than lumps.
The finding that independent risk factors for patient delay
included not disclosing the discovery of a symptom and needing to
be prompted to attend the GP by someone else suggest that
womens' help-seeking behaviour is responsive to social influences.
This is in line with other work that has shown that the expectations
and influence of significant others (e.g. spouses, siblings and chil-
dren) can determine medical help-seeking behaviour in relation not
only to the symptoms ofcancer (Coates et al, 1992; Facione, 1993)
but also ofother illnesses (Zola, 1973; Cameron et al, 1993).
A large multicentre study is now warranted to further test the
hypotheses generated by this single institution project. The highly
significant finding that non-lump symptoms are a risk factor for
both patient and GP delay requires further validation, as well as
further definition to look at which particular non-lump presenta-
tions may constitute particular risk for delay. Similarly the rela-
tionship between delayed presentation and social influences on
women needs to be clarified. Is it the presence or absence of a
social attachment in itself that is important, or does the quality of
the attachment play a part?
Our study has not demonstrated any ofthe associations between
sociodemographic variables, including ethnicity and socioeco-
nomic class, and delay that were reported in North American
studies, e.g. (Fisher et al, 1977; Vernon et al, 1985; Samet et al,
1988; Richardson et al, 1992). A large multicentre study with a
broad racial and sociodemographic mix of patients will enable
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those women who are at high risk ofdelay in terms oftheir social
and demographic characteristics to be identified, so that effective
interventions may be targeted appropriately.
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